Literature DB >> 14716519

Weekly administration of paclitaxel attenuated rectal stenosis caused by multiple peritoneal recurrence 8 years after the resection of gastric carcinoma.

Yoichi Sakurai1, Ikuo Yoshida, Shuhei Tonomura, Wakana Sakai, Yasuko Nakamura, Hiroki Imazu, Toshiki Matsubara, Masahiro Ochiai.   

Abstract

We report a patient with rectal stenosis caused by peritoneal recurrence 8 years after a curative resection of advanced stage gastric carcinoma; the recurrence was effectively treated with the weekly administration of paclitaxel. The patient was a 66-year-old Japanese woman who was admitted to our hospital complaining of abdominal pain and frequent bowel movements. She had undergone total gastrectomy, due to advanced-stage gastric carcinoma with extensive lymph node metastasis, 8 years before, and had taken an oral anticancer agent, fluoropyrimidine, for 4 years after the operation. Colonofiberscopy performed on admission revealed circumferential rectal stenosis located 10 cm from the anal verge. Barium enema study demonstrated extensive poor expansion of the upper and lower rectum and irregularity of the descending colon. Abdominal computed tomography (CT) scanning revealed wall thickening in the rectum and descending colon. These findings were compatible with rectal stenosis caused by the peritoneal recurrence of gastric carcinoma. Weekly administration of paclitaxel was started. The abdominal symptoms soon disappeared when the second cycle of paclitaxel was completed, and they have not appeared since then. The rectal stenosis was attenuated, as confirmed by imaging analyses. Weekly paclitaxel has been effective for more than 13 months, suggesting that the patient is in a state of tumor dormancy of recurrent gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14716519     DOI: 10.1007/s10120-003-0250-7

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  2 in total

1.  Unresectable gastric cancer with multiple liver metastases effectively treated with combined paclitaxel and doxifluridine chemotherapy.

Authors:  Shin Mizutani; Tsukasa Oyama; Nobutaka Hatanaka; Fumihiro Uchikoshi; Katsuhide Yoshidome; Masayuki Tori; Shigeyuki Ueshima; Masaaki Nakahara; Kazuyasu Nakao
Journal:  Int J Clin Oncol       Date:  2006-12-25       Impact factor: 3.402

2.  Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

Authors:  Tomoya Tsukada; Sachio Fushida; Shinichi Harada; Shiroh Terai; Yasumichi Yagi; Jun Kinoshita; Katsunobu Oyama; Hidehiro Tajima; Itasu Ninomiya; Takashi Fujimura; Tetsuo Ohta
Journal:  Int J Oncol       Date:  2013-01-29       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.